MIPS: Multicenter Italian Pneumonia Study. Results of an observational, prospective and multicenter study on the clinical approach to community-acquired pneumonia;MIPS: Multicenter Italian Pneumonia Study. Risultati di uno studio osservazionale, prospettico e multicentrico sulla gestione clinica delle polmoniti acquisite in comunità

Infezioni in Medicina

Volumn 12, Issue 3, 2004, Pages 181-185

  Artom, Alberto ^a   Artom, Patrizia ^b   Rattenni, Sergio ^a   Castello, Cristoforo ^c   Lo Pinto, Giuliano ^d  

^a SANTA CORONA HOSPITAL   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Evangelico Hospital Genova   (Italy)

^d GALLIERA HOSPITAL   (Italy)

Author keywords

Antimicrobial therapy; Community acquired pneumonia; Guidelines

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

AGED; AGING; ANTIBIOTIC THERAPY; BLOOD GAS ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; ITALY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMONIA; REVIEW; SCORING SYSTEM; THORAX RADIOGRAPHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DRUG UTILIZATION; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; ITALY; LENGTH OF STAY; MALE; MIDDLE AGED; PNEUMONIA; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 7044235084     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Murray C.J.L. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349, 1269-1276, 1997.
2. Bartlett J.G., Mundy L.M. Community-acquired pneumonia. N. Engl. J. Med. 393, 1618-1624, 1995.
3. Pinner R.W., Teutsch S.M., Simonsen L., et al. Trends in infectious diseases mortality in the United States. JAMA 275, 189-193, 1996.
4. Niederman M.S., Mc Combs J., Unger A., et al. The cost of treating community-acquired pneumonia. Clin. Ther. 20, 820-836, 1998.
5. Fine M.J., Pratt H.M., Obrosky D.S., et al. Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia. Am. J. Med. 109, 378-385, 2000.
6. Fine M.J., Auble T.E., Yealy D.M., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl. J. Med. 336, 243-250, 1997.
7. Bartlett J.G., Dowell S.F., Mandell L.A., et al. Practice guidelines for the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 31, 347-382, 2000.
8. Mandell L.A., Marrie T.J., Grossman R.F., et al. Canadian guidelines for the initial management of community-acquired pneumonia. Clin. Infect. Dis. 31, 383-421, 2000.
9. Niederman M.S., Mandell L.A., Anzueto A., et al. Guidelines for the management of adults with community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 63(7), 1730-1754, 2001.
10. British Thoracic Society. Community-acquired pneumonia guidelines. Thorax 56, suppl. 4, 1-64, 2001.
11. Artom A., Anselmo M., Castello C., et al. Gestione della polmonite acquisita in comunità negli Ospedali Liguri. Risultati dello Studio Ligure Ospedale/Università sulle polmoniti acquisite in Comunità (SLOUP), uno studio osservazionale multicentrico. GIMI 2, (2), 40-48, 2003.
12. File T.M. Community-acquired pneumonia. Lancet 362, 1991-2001, 2003.
13. Houch P.M., Bratzler D.W., Nsa W., et al. Timing of antibiotic administration and outcomes for medicare patients hospitalized with community-acquired pneumonia. Arch. Intern. Med. 164, 637-664, 2004.
14. Genne D., Kaiser L., Kinge T.N., et al. Community-acquired pneumonia: causes of treatment failure in patients enrolled in clinical trials. Clin. Microbiol. Infect. 9, 949-954, 2003.
15. Fine MJ, Stone RA, Singer DE, et al. Processes and outcomes of care for patients with community-acquired pneumonia. Arch. Intern. Med. 159, 970-980, 1999.
16. Gleason P.P., Meehan T.P., Fine J.M., et al. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch. Intern. Med. 159, 2562-2572, 1999.
17. Marrie T.J., Lau C.Y., Wheeler S.L., et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. JAMA 283, 749-755, 2000.
18. Arnold F.W., Ramirez J.A., McDonald L.C., et al. Hospitalization for community-acquired pneumonia. The Pneumonia Severity Index vs Clinical Judgement. Chest 124, 121-124, 2003.
19. Metlay J.P., Fine M.J. Testing strategies in the initial management of patients with community-acquired pneumonia. Ann. Intern. Med. 138, 109-118, 2003.